BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Substance Use Disorder readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Substance Use Disorde
 r\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07420283-822@assetmemo.bio
DTSTAMP:20261121T005427Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Brenipatide: Phase 2 readout est. (NCT07420283)
DESCRIPTION:Brenipatide\, phase 2\, Opioid Use Disorder.\nStudy: A Study of
  Brenipatide in Participants With Opioid Use Disorder\nEstimated primary c
 ompletion: March 2028. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/brenipatide#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07420283
URL:https://assetmemo.bio/drug/brenipatide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
